Concourse Financial Group Securities, Inc. Protagonist Therapeutics, Inc Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$33.72 - $47.33 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$24.66 - $34.8 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$21.79 - $32.15 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$14.05 - $23.44 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$16.68 - $23.66 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$16.68 - $23.66 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$18.02 - $29.36 $0 - $0
Q1 2023 May 15, 2023	BUY	$10.78 - $25.38 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$7.36 - $11.17 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$7.86 - $11.71 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$7.06 - $25.52 $0 - $0
Q1 2022 May 09, 2022	BUY	$23.34 - $36.08 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$17.63 - $37.1 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$12.95 - $49.69 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$25.57 - $44.88 $0 - $0
Q1 2021 May 13, 2021	BUY	$19.02 - $31.15 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$18.49 - $25.13 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$15.19 - $22.4 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$6.19 - $18.84 $0 - $0
Q1 2020 May 13, 2020	BUY	$5.4 - $9.22 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$4.69 - $13.45 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$9.41 - $16.56 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$8.98 - $12.96 $0 - $0
Q1 2019 May 15, 2019	BUY	$6.5 - $13.77 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$6.3 - $10.44 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$6.82 - $11.26 $0 - $0

Others Institutions Holding PTGX

# of Institutions

247

Shares Held

56.4M

Call Options Held

76.3K

Put Options Held

114K

Farallon Capital Management LLC San Francisco, CA

5.86M
Shares

$263 Million
1.32% of portfolio
Black Rock Inc. New York, NY

5.76M
Shares

$258 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.43M
Shares

$243 Million
3.89% of portfolio
Vanguard Group Inc Valley Forge, PA

4.22M
Shares

$189 Million
0.0% of portfolio
State Street Corp Boston, MA

3.18M
Shares

$143 Million
0.01% of portfolio

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.2B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account